Motor neuron disease (amyotrophic lateral sclerosis). (Q37627030)

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Primary lateral sclerosis. A clinical diagnosis reemerges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor-neuron disease in natives of New Guinea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

An endemic neurological disorder in tribal Australian aborigines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Cycads and amyotrophic lateral sclerosis/parkinsonism dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Increasing trend of ALS in France and elsewhere: are the changes real?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor neuron disease in England and Wales, 1959-1979

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Changing mortality patterns of motor neuron disease in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

The central nervous system in motor neurone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Recent views on amyotrophic lateral sclerosis with emphasis on electrophysiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor neuron disease in the Province of Turin, Italy, 1971-1980.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis in Limousin (Limoges area, France)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Changes in the incidence of amyotrophic lateral sclerosis in Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Rising mortality from motoneuron disease in the USA, 1962-84.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

A case-control study of amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis. A study of its presentation and prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

A longitudinal study of changes in motor units in motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

The natural history of motoneuron loss in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor neurone disease with elevated cerebrospinal fluid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis with ophthalmoplegia. A clinicopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

An eye movement disorder in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Nystagmus in motor neuron disease: clinicopathological study of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Frequency of nerve fiber degeneration of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. Morphometry of deep and superficial peroneal nerves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Familial adult motor neuron disease: amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor neuron disease (ALS): evaluation of detection thresholds of cutaneous sensation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Shy-Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

The relationship between Alzheimer's disease, Parkinson's disease and motor neuron disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Quantitative axon terminal and end-plate morphology in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor unit estimates in the biceps-brachialis in amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

The distribution and frequency of spontaneous fasciculations in motor neurone disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

From benign fasciculations and cramps to motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Fasciculations and their F-response. Localisation of their axonal origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Abnormal sensory evoked potentials in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Evoked potentials in motor system diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Degeneration of the human Betz cell due to amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Size-dependent myelinated fiber loss in the corticospinal tract in Shy-Drager syndrome and amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Pathology of myelinated fibers in cervical and lumbar ventral spinal roots in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Regular involvement of Clarke's nucleus in sporadic amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Neurofibrillary axonal swellings and amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Electron microscopy of focal neuroaxonal lesions produced by beta-beta-iminodipropionitrile (IDPN) in rats. I. The advanced lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Neurofibrillary axonal pathology in aluminum intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Swellings of proximal axons in a case of motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Morphometry of the degenerative process in the hypoglossal nerves in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Morphometry of intramuscular nerves in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Permanent Axotomy by Amputation Results in Loss of Motor Neurons in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Heterotopic neurons in spinal cord of patients with ALS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Familial motor neuron disease: differing penetrance in large pedigrees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

An inherited disease similar to amyotrophic lateral sclerosis with a pattern of posterior column involvement. An intermediate form?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Familial amyotrophic lateral sclerosis: features of multisystem degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Phenotypic and genotypic heterogeneity of dominantly inherited amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Linkage analysis in familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Hypothesis: interference with axonal transport of neurofilament as a common pathogenetic mechanism in certain diseases of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Axonal transport in neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Fast axonal transport alterations in amyotrophic lateral sclerosis (ALS) and in parathyroid hormone (PTH)-treated axons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Reduction of the naturally occurring motor neuron loss by enlargement of the periphery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Distinct neurotrophic factors from skeletal muscle and the central nervous system interact synergistically to support the survival of cultured embryonic spinal motor neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Naturally-occurring neuron death in the ciliary ganglion of the chick embryo following removal of preganglionic input: evidence for the role of afferents in ganglion cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Evidence for a motor nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Trophic factors in neurologic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Possible role of androgen receptors in amyotrophic lateral sclerosis. A hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Gender-specific action of thyrotropin-releasing hormone in the mammalian spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Evidence for immune-complex formation in patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor neuron disease and plasma cell dyscrasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis: an unconventional autoimmune disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor Neurone Disease: an Immunological Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Lymphocytotix antibodies in subacute sclerosing panencephalitis and amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Immunoregulatory and activated T cells in amyotrophic lateral sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Cell-mediated immunity to polio and HLA antigens in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Kidney and skin biopsy in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Histocompatibility typing in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

HLA frequencies in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Neuropathy and motor neuron syndromes associated with plasma cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Macroglobulinemia with peripheral neuropathy simulating motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor neuron disease and paraproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis and paraproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Antineural antibodies in the serum of patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

A new hypothesis of the etiology of amyotrophic lateral sclerosis. The DNA hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Deficient DNA repair in amyotrophic lateral sclerosis cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Spontaneous and mutagen-induced sister chromatid exchange in motor neurone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

7 January 2021

Hyperinsulin neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Glucose metabolism and insulin response in the plasma and CSF in motor neurone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Insulin resistance in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Enzymatic analysis of individual anterior horn cells in amyotrophic lateral sclerosis and duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Cultures of tissues from patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Antibody response to arboviruses. Absence of increased response in amyotrophic lateral sclerosis and multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

CSF viral antibodies. Evaluation in amyotrophic lateral sclerosis and late-onset postpoliomyelitis progressive muscular atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Viruslike particles in amyotrophic lateral sclerosis: electron microscopical study of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic Lateral Sclerosis With Antecedent Poliomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Attempts to demonstrate virus in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motoneuron disease and past poliomyelitis in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Virological studies in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis: Search for poliovirus by nucleic acid hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Detection of picornavirus sequences in nervous tissue of amyotrophic lateral sclerosis and control patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Thyroid function in 44 patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Further studies on the erythrocyte uptake of lead in vitro in amyotrophic lateral sclerosis (ALS) patients and controls. Abnormal erythrocyte fragility in ALS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Specificity of biophysical and biochemical alterations in erythrocyte membranes in neurological disorders--Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Neuromuscular disease in primary hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

The pathogenesis of amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

The calcium-magnesium-deficient rat: a study on the distribution of calcium in the spinal cord using the electron probe microanalyser

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Calcium and vitamin D metabolism in Guamanian Chamorros with amyotrophic lateral sclerosis and parkinsonism-dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motoneurone disease and ageing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Age effects on properties of motor unit action potentials: ADEMG analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

The numbers of limb motor neurons in the human lumbosacral cord throughout life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Lipofuscin in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

DNA damage as the primary cause of aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis: effect of serum on anterior horn cells in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic Lateral Sclerosis Sera Applied to Cultured Motor Neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Neuron specific in vitro cytotoxicity of sera from patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Nature and properties of cytotoxic plasma activity in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Passive transfer experiments in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Effects of amyotrophic lateral sclerosis sera on cultured cholinergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

CSF from amyotrophic lateral sclerosis patients applied to motor neurons in culture fails to alter neuron-specific enolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Cultured rat spinal cord neurons: interaction with motor neuron disease immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Effects of amyotrophic lateral sclerosis serum on cultured chick spinal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Xenobiotic metabolism in motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

S-methylation in motorneuron disease and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

A cohort study of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam and Rota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Reversible forms of motor neuron disease. Lead "neuritis".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

ALS and heavy metals: a pilot case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Abnormal distribution of lead in amyotrophic lateral sclerosis--reestimation of lead in the cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Long-time penicillamine-treatment in amyotrophic lateral sclerosis with parallel determination of lead in blood, plasma and urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Metals in spinal cord tissue of patients dying of motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Increased spinal cord lead content in amyotrophic lateral sclerosis — Possibly a secondary phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Response to penicillamine of lead concentrations in CSF and blood in patients with motor neurone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Alterations in short-term retention, conditioned avoidance response acquisition and motivation following aluminum induced neurofibrillary degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION 2. ELECTRON MICROSCOPY, PHOSPHATASE HISTOCHEMISTRY AND ELECTRON PROBE ANALYSIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Low-calcium, high-aluminum diet-induced motor neuron pathology in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Free amino acid concentrations in spinal tissue from patients dying of motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Neurological disorders associated with deficiency of glutamate dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Abnormal glutamate metabolism in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Free amino acid levels in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amyotrophic lateral sclerosis: Alterations in neurotransmitter receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Alterations in receptors for thyrotropin-releasing hormone, serotonin, and acetylcholine in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Reduced glycine receptor in the spinal cord in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Substance P receptors in the human spinal cord: decrease in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Choline acetyltransferase activities in single spinal motor neurons from patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Norepinephrine and gamma-aminobutyric acid in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Neurotransmitter abnormalities in patients with motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Monoamine oxidase (MAO), 5-hydroxyindole acetic acid (5 HIAA) and homovanillic acid (HVA) in motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Juvenile spinal muscular atrophy: a new hexosaminidase deficiency phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Clinical and genetic variations in the syndrome of adult GM2 gangliodosis resulting from hexosaminidase a deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Hexosaminidase A activity and amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Autosomal dominant inheritance of hereditary canine spinal muscular atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

The wobbler mouse mutant: an animal model of hereditary motor system disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Murine motor neuron disease (the wobbler mouse): degeneration and regeneration of the lower motor neuron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Abnormal RNA metabolism in spinal motor neurons in the wobbler mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Impairment of retrograde axonal transport in wobbler mouse motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Slow Axonal Transport of Neurofilament Proteins: Impairment of β,β′-Iminodipropionitrile Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Outpatient management of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Myasthenic syndrome in patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Pathologic laughing and crying treated with levodopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Treatment of pathologic laughing and weeping with amitriptyline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Motor neurone disease: can we do better? A study of 42 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Respiratory complications and their management in motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Protirelin (thyrotropin-releasing hormone) in amyotrophic lateral sclerosis. The role of androgens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Use of TRH analogues in motorneurone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Plasmapheresis in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Plasmapheresis with immunosuppression in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Failure of immunosuppression with a ten- to 14-day course of high-dose intravenous cyclophosphamide to alter the progression of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Transfer factor is ineffective in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Amantadine and guanidine are ineffective in ALS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Administration of recombinant human leukocyte alpha 2-interferon in patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Intrathecal administration of natural human interferon alpha in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Response of patients with amyotrophic lateral sclerosis to testosterone therapy: endocrine evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Pilot trial of branched-chain aminoacids in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

Glucose tolerance in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Motor neurone disease: towards better care

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961175-6